Journal article

How good is HIV envelope glycoprotein vaccine as a T-lymphocyte stimulant?

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Michie, C., Vyakarnam, A., & Beverley, P. (1991). How good is HIV envelope glycoprotein vaccine as a T-lymphocyte stimulant? Lancet, 338(8760), 187.

MLA Style

Michie, C., et al. “How Good Is HIV Envelope Glycoprotein Vaccine as a T-Lymphocyte Stimulant?” Lancet, vol. 338, no. 8760, 1991, p. 187.

Chicago Style

Michie, C, A Vyakarnam, and P Beverley. 1991. “How Good Is HIV Envelope Glycoprotein Vaccine as a T-Lymphocyte Stimulant?” Lancet 338 (8760): 187.
Share
Print

Access Document

Publisher copy:: 10.1016/0140-6736(91)90176-p

Authors

+ Michie, C More by this author

Role:: Author

+ Vyakarnam, A More by this author

Role:: Author

+ Beverley, P More by this author

Institution:: University of Oxford
Division:: MSD
Department:: NDM
Sub department:: NDM Experimental Medicine
Role:: Author

Journal:: Lancet More from this journal
Volume:: 338
Issue:: 8760
Pages:: 187
Publication date:: 1991-07-01
DOI:: 10.1016/0140-6736(91)90176-p
EISSN:: 1474-547X
ISSN:: 0140-6736

Language:: English
Keywords:: HIV Envelope Protein gp160

T-Lymphocytes

Lymphocyte Activation

Protein Precursors

Vaccines, Synthetic

Gene Products, env

Humans
Pubs id:: pubs:33503
UUID:: uuid:4a141471-c707-4bf3-b69f-50251377f40d
Local pid:: pubs:33503
Source identifiers:: 33503
Deposit date:: 2012-12-20

Terms of use

Copyright date:: 1991

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP